Deadline: May 7, 2018
About Grand Pharmaceutical (China) Co. Ltd
Main business: Science and pharmaceuticals
GRANDPHARM (original Wuhan Pharmaceutical Company) was founded in 1939 as a medical material factory for Eighth Route Army during the WW II. Through the merge into China Grand Enterprises in 2002, GRANDPHARMA has been evolving its business from bulk API to high-end ingredients production, transforming itself upstream to producing innovative drugs and downstream to producing preparations. After becoming the main enterprise of Hong Kong-listed parent company (HK: 00512) and through acquisition of 18 domestic and international companies, Grandpharma has now become China's largest ophthalmology & otorhinolaryngology Pharmaceutical Group, one of a few China's cardiovascular first-aid medicine provider and the world's top drug coated balloon technology owner.
Headquartered in Wuhan, GRANDPHARM’s subsidiaries are distributed across Hubei Province and in Beijing, Tianjin, Xi’an, Zhuhai. Our products are sold to tens of different countries and regions around Asia, Europe, and America. The company’s annual sales revenue amounted to 3 billion RMB, with annual export earnings of 58 million USD. We have over 6,000 employees, including over 2,000 in sales promotion, and an independent R&D center operated by over 200 professionals. In addition, we have hired world-renowned pharmaceutical experts from U.S., New Zealand, Australia and India, etc. The successful commercialized production of L – cysteine and citrulline through microbial fermentation, which was introduced by Dr. Ouyang Hui, the chief bioengineering scientist in GRANDPHARMA, has fulfilled the gap of large production of cysteine in China.
About the programme:
The program is tailored to recent graduates, who hold a Master's degree or above, with no more than 3 years’ experiences, possessing a good business acumen, development potential, and commitment to success and leadership.
Our program is designed to grow you into a professional manager in various areas of the company. In the framework of a 3 years’ trainee program, you will be rotated cross-function or even cross-subsidiaries. Centered around your major, you will also have the opportunities to work overseas. Show great results after 3 years, and we’ll expect you to embrace your next challenge in a more senior role.
How to apply:
Please apply via the website: http://www.grandpharma.cn/en/Human/join.aspx